Evoke Pharma's market cap is currently ―. The company's EPS TTM is $-2.33; its P/E ratio is -0.19; Evoke Pharma is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.68M	$ 1.56M	$ 1.13M	$ 810.41K	$ 796.37K
Gross Profit	$ 1.68M	$ 1.56M	$ 1.13M	$ 810.41K	$ 796.37K
EBIT	$ -1.74M	$ -1.50M	$ -1.63M	$ -2.12M	$ -1.71M
EBITDA	$ -1.74M	$ -1.50M	$ -1.63M	$ -2.12M	$ -1.71M
Net Income Common Stockholders	$ -1.99M	$ -1.62M	$ -1.87M	$ -2.24M	$ -1.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.70M	$ 6.00M	$ 7.00M	$ 8.20M	$ 9.80M
Total Assets	$ 7.07M	$ 7.85M	$ 8.97M	$ 10.03M	$ 11.85M
Total Debt	$ 5.00M	$ 5.01M	$ 5.05M	$ 5.09M	$ 5.13M
Net Debt	$ 300.00K	$ -986.63K	$ -1.95M	$ -3.11M	$ -4.67M
Total Liabilities	$ 9.65M	$ 8.73M	$ 8.44M	$ 7.91M	$ 7.77M
Stockholders Equity	$ -2.58M	$ -873.77K	$ 538.37K	$ 2.13M	$ 4.08M
Cash Flow	-
Free Cash Flow	$ -1.11M	$ -1.04M	$ -1.21M	$ -1.63M	$ -2.51M
Operating Cash Flow	$ -1.11M	$ -1.04M	$ -1.21M	$ -1.63M	$ -2.51M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -119.30K	-	-	-	-

Currency in USD

Evoke Pharma Earnings and Revenue History

Income Statement >

Evoke Pharma Debt to Assets

Balance Sheet >

Evoke Pharma Cash Flow

Cash Flow >

Evoke Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing